TP53 and non-small cell lung carcinoma: As our study demonstrated that quisinostat treatment of A549 cells resulted in p53 up-acetylation, we further examined the effects of quisinostat on H460—a wild-type p53-expressed NSCLC cell line—and H1299—a p53-defective NSCLC cell line.